Gabapentin as a possible treatment of behavioral alterations in Alzheimer disease (AD) patients.
Moretti
R
R
Torre
P
P
Antonello
R M
RM
Cazzato
G
G
D000085:Acetates / Q000627:therapeutic use*; D000368:Aged; D000544:Alzheimer Disease / Q000188:drug therapy* / Q000523:psychology*; D000588:Amines; D001519:Behavior / Q000187:drug effects; D003509:Cyclohexanecarboxylic Acids; D018690:Excitatory Amino Acid Agonists / Q000627:therapeutic use*; D005260:Female; D000077206:Gabapentin; D006801:Humans; D008297:Male; D005680:gamma-Aminobutyric Acid
D000085:Acetates; D000588:Amines; D003509:Cyclohexanecarboxylic Acids; D018690:Excitatory Amino Acid Agonists; D005680:gamma-Aminobutyric Acid; D000077206:Gabapentin